Fundraising Fox

Soteria Biotherapeutics

San Francisco, US · Founded 2018 · Delaware corporation · 1 employees on LinkedIn · 3 known investors

Find your way into Soteria Biotherapeutics

319 people in our graph share verified history with the Soteria Biotherapeutics team — schools, employers, funds. One of them is your warm intro.

Andrewunlockedknows Zachary Hill · together at University of Washington (overlapped)
×4knows the team · via University of Washington
×4knows the team · via Ey
knows the team · via Antiva Biosciences
knows the team · via Exelixis
knows the team · via University of California, San Francisco
Biotech

Founders & leadership

KMKristine M Ball
Kristine M BallinChief Executive Officer2020–2022Executive Officer, Director at Antiva Biosciences
ZHZachary Hill
Zachary HillinCo-Founder2018–2022Zachary Hill is VP of Discovery Chemistry at Montara Therapeutics, leading small molecule identification for their therapeutics platform. He has over 15 years of research experience in small molecule synthesis and protein engineering applied to therapeutic development, including doctoral training under Dustin Maly at the University of Washington and postdoctoral work with Jim Wells at UCSF.

Board

NM
Nisha MaratheBoard director
DADavid Allison
David AllisoninBoard directorManaging Director at Westlake Village BioPartners
KGKeno Gutierrez
Keno GutierrezinBoard Member and Observer2018–2021General Partner at BioGeneration Ventures
DM
David MorrisBoard director
SJ
Steve JamesBoard director
MW
Momo WuBoard director

Investors · 3

5AM VenturesreportedBoston · $100K – $4M
Roche Venture FundreportedBasel · $648K – $3.2M
Westlake Village BioPartnersreported · 2 sourcesLos Angeles · $100K – $5Mvia David Allison · board

Reported raises · per SEC filings

Form D private placements

$24.9M disclosed across 1 round · 2021

▶$24.9MraisedMay 2021 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Nisha MaratheDirector
  • Kristine M BallExecutive Officer, Director
  • David AllisonDirector
  • Keno GutierrezDirector
  • David MorrisDirector
  • Steve JamesDirector
  • Momo WuDirector
  • Zachary HillExecutive Officer, Director
Offering amount
$42.2M
Amount sold
$24.9M
First sale
May 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Soteria Biotherapeutics Raises $42M in Series A Financingfinsmes.com · May 2021Discovering Biotech Startups: A map for Selling to Soteria Biotherapeuticsblog.zymewire.com · Mar 2020

Frequently asked questions

Who are Soteria Biotherapeutics's investors?
Soteria Biotherapeutics's investors include 5AM Ventures, Roche Venture Fund, Westlake Village BioPartners.
How much funding has Soteria Biotherapeutics raised?
Soteria Biotherapeutics has disclosed $24.9M raised across 1 round.
Where is Soteria Biotherapeutics headquartered?
Soteria Biotherapeutics is headquartered in San Francisco, US.